http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-2014295-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6df885157441d009872c020ab4a1d203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70ccbd570c4f2ccf43119230b334d7bd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048 |
| filingDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a256deb8f3d786bab8ae064ba91ed161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_536e8b14d11f2e6454e2d33e5d9c250a |
| publicationDate | 2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-2014295-A3 |
| titleOfInvention | Substituted furo [3,2-b] pyridines for use as medicaments |
| abstract | The present invention provides substituted furo [3,2-b] pyridines of the formula I, or pharmaceutically acceptable salts or solvates thereof, wherein R 1 is phenyl or naphthyl, optionally substituted with a substituent selected from the group consisting of methyl, methoxy, methylthio, F, Cl, Br; R.sup.2 is selected from the group consisting of -NR.sup.3.n (p.sup.3.n..sup.R5.n.) PNR.sup.6.n..sup. R7.n.or –NR.sup.3.n. (CR.sup.4.n..up.R5.n.) Sub.pnOR.sup.8.n; R 3 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl; R 4 is H; R 5 is H; R 6 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl; R 7 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl; R 8 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl; p is in the range of 2 to 7. These substances are suitable for use as medicaments, in particular for the treatment of hematological malignancies. |
| priorityDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.